Sunday, June 5, 2022
- 6:30pm-6:40pm
-
Post-Kidney Donation Pregnancy Complications and Long-Term Outcomes
Kidney Living Donor: Long Term Outcomes • Hynes Room 206
- 6:30pm-6:40pm
-
Predictors of Response to Belatacept Conversion in Kidney Transplant Patients with Chronic Active Antibody-Mediated Rejection
- 6:30pm-6:40pm
-
Pregnancy After Heart Transplant Does Not Negatively Impact Long Term Patient Survival
Heart and VADs: All Topics I • Hynes Room 210
- 6:30pm-6:40pm
-
Reduction of Discharge Opioid Prescriptions After Kidney Transplantation: A Quality Improvement Project
Non-Organ Specific: Clinical Pharmacy/Transplant Pharmacotherapy • Hynes Room 312
- 6:30pm-6:40pm
-
Renal Failure is Reversible in the Majority of Patients Transplanted for Alcohol-Associated Hepatitis: A Review of the UNOS Database
Cirrhosis: Complications, Portal Hypertension and Renal Management • Hynes Room 311
- 6:30pm-6:40pm
-
The Enhanced Recovery After Surgery (ERAS) Program for Donor Hepatectomy; Useful Method for Donor Safety? Or Unnecessary Hindrance?
Surgery innovative Techniques Including Living Donor • Hynes Room 313
- 6:40pm-6:50pm
-
Combined Heart-Liver Transplantation for Failing Fontan Physiology: A Large Single Center Comparative Analysis
Heart and VADs: All Topics I • Hynes Room 210
- 6:40pm-6:50pm
-
Creating a Workflow for the Electronic Medical Record Allows Living Donor Liver Transplantation Programs to Track Candidates and Identify Areas for Optimization
Surgery innovative Techniques Including Living Donor • Hynes Room 313
- 6:40pm-6:50pm
-
Donor-Derived Cell-Free DNA as a Biomarker of T Cell Mediated Rejection in Pediatric Kidney Transplant Patients
Kidney: Pediatrics • Hynes Ballroom C
- 6:40pm-6:50pm
-
FasL-Presenting PEG Microgels Supports Sustained Graft Survival in Nonhuman Primates in the Absence of Continuous Immunosuppression
Immunosuppression and Tolerance: Preclinical and Translational Studies • Hynes Ballroom A
- «Previous Page
- 1
- …
- 17
- 18
- 19
- 20
- 21
- …
- 54
- Next Page»